Trial intelligence / Profile preview

Plenvu vs Picoprep for Bowel Cleansing Before Colonoscopy

2024-518544-21-00Phase 4Authorised

Sponsor
Aalborg University Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in colorectal cancer (CRC) comparing Plenvu with Picoprep (2 arms). Primary endpoint: Efficacy non-inferiority of Plenvu vs Picoprep. Planned start Nov 2024; status: authorised.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acidsodium picosulfate
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on 2024-518544-21-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518544-21-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call